ArticleAdvances in experimental medicine and biology2024

Development of Orally Ingestible IgA Antibody Drugs to Maintain Symbiosis Between Humans and Microorganisms.

Reiko ShinkuraPubMed ↗Publisher ↗

No numbers read from the abstract.